enVVeno Medical posts Q2 2026 results, gets FDA nod for venous valve trial

Go back to enVVeno Medical posts Q2 2026 results, gets FDA nod for venous valve trial
(NASDAQ: NVNO) Delayed: 10.60 -0.03 (0.28%)
Previous Close $10.63    52 Week High
Open $10.60    52 Week Low
Day High $10.60    P/E N/A 
Day Low $10.60    EPS
Volume 2,338